Cargando…
International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer’s Disease
Alzheimer’s disease (AD) is the main cause of dementia, with its diagnosis and management remaining challenging. Amyloid positron emission tomography (PET) has become increasingly important in medical practice for patients with AD. To integrate and update previous guidelines in the field, a task gro...
Autores principales: | Tian, Mei, Zuo, Chuantao, Civelek, Ali Cahid, Carrio, Ignasi, Watanabe, Yasuyoshi, Kang, Keon Wook, Murakami, Koji, Garibotto, Valentina, Prior, John O., Barthel, Henryk, Guan, Yihui, Lu, Jiaying, Zhou, Rui, Jin, Chentao, Wu, Shuang, Zhang, Xiaohui, Zhong, Yan, Zhang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425321/ https://www.ncbi.nlm.nih.gov/pubmed/37589025 http://dx.doi.org/10.1007/s43657-022-00068-9 |
Ejemplares similares
-
International consensus on the use of tau PET imaging agent (18)F-flortaucipir in Alzheimer’s disease
por: Tian, Mei, et al.
Publicado: (2022) -
Molecular Image-Guided Theranostic and Personalized Medicine 2013
por: Zhang, Hong, et al.
Publicado: (2014) -
Molecular Image-Guided Theranostic and Personalized Medicine 2014
por: Zhang, Hong, et al.
Publicado: (2015) -
Editorial: Artificial Intelligence in Positron Emission Tomography
por: Fang, Hanyi, et al.
Publicado: (2022) -
Editorial: Global excellence in nuclear medicine: North America
por: Jha, Abhishek, et al.
Publicado: (2023)